Merck Animal Health, a unit of Merck, said on Thursday it would invest $895 million to expand its manufacturing facility in De Soto, Kansas.The capital expansion includes an investment of $860 million in the site's existing manufacturing facility and a further $35 million in its research and development laboratories,

Merck (NYSE:MRK) on Thursday announced plans to invest $895M to expand a manufacturing facility in Kansas, becoming the latest pharma major to boost capital expenditure in the U.S. amid the Trump administration’s tariff threats.

A new manufacturing plant in De Soto will be a Center of Excellence for the global company, along with expanded R&D capabilities at the site.